Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LATITUDE: Abiraterone + Prednisone in High-Risk mHNPC
NCT01715285Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Feb 2013
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 33
01
Overview
A Phase 3 trial of Abiraterone Acetate Tablets (I) in prostate cancer (PCa), sponsored by Janssen Pharmaceutical. Started Feb 2013; status: completed.
02
Drugs
Abiraterone Acetate Tablets (I)
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01715285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01715285.